Entrada Therapeutics (TRDA)
(Delayed Data from NSDQ)
$12.34 USD
-0.11 (-0.88%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $12.34 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/08/2024
Time: -- |
3/2024 | $-0.38 | 97.37% |
Earnings Summary
For their last quarter, Entrada Therapeutics (TRDA) reported earnings of -$0.29 per share, missing the Zacks Consensus Estimate of -$0.07 per share. This reflects a negative earnings surprise of 314.29%. Look out for TRDA's next earnings release expected on May 08, 2024. For the next earning release, we expect the company to report earnings of -$0.38 per share, reflecting a year-over-year decrease of 80.95%.
Earnings History
Price & Consensus
Zacks News for TRDA
Exelixis (EXEL) Posts Preliminary 2023 Results, to Cut 13% Jobs
TRDA: What are Zacks experts saying now?
Zacks Private Portfolio Services